Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$38,832,013
+$34,361,206 QoQ
Shares Held
152,900
+736.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#514
of 4,676 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AustralianSuper Pty Ltd holds $1,190,287,072 across 9 Drug Manufacturers - General names. JNJ ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
469,702 | $563,374,716 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
1,271,457 | $160,635,877 | |
| 3 | BIIB |
Biogen Inc.
|
672,723 | $145,348,531 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,433,354 | $140,209,857 | |
| 5 | ABBV |
AbbVie Inc.
|
426,658 | $107,364,219 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
152,900 | $38,832,013 | |
| 7 | PFE |
Pfizer Inc
|
968,550 | $23,322,684 | |
| 8 | MRK |
Merck & Co., Inc.
|
77,831 | $10,001,283 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,832,013 | 152,900 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,470,807 | 18,290 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,785,115 | 18,290 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $16,536,311 | 89,183 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,860,953 | 12,183 | Shares | Sole | 2025-08-01 | |
| 2024-03-31 | $1,577,312 | 9,971 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $93,510,613 | 596,597 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $135,703,729 | 871,292 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $183,582,038 | 1,109,123 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $157,375,685 | 1,015,327 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $161,788,788 | 915,872 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $153,928,900 | 942,268 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $88,903,398 | 500,836 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $68,579,857 | 386,954 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $49,836,625 | 291,323 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $47,933,523 | 296,802 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $41,006,751 | 248,918 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $51,747,405 | 314,861 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $205,298,590 | 1,304,477 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $173,111,113 | 1,162,756 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $150,386,065 | 1,069,374 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $216,431,114 | 1,650,508 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||